SLC16A9 and kidney neoplasm: SLC16A9 was highly expressed in the C3 (inflammatory) and C4 (lymphocyte depleted) immune subtypes of all three different subtypes of kidney tumors (KICH, KIRC and KIRP) (Figure 7g), and it was lowly expressed in the C2c-CIMP molecular subtype of KIRP (Figure 7h).